CHA Bio & Diostech to acquire 30.6% stake in Skynewpharm - MarketLine Financial Deals

CHA Bio & Diostech to acquire 30.6% stake in Skynewpharm

CHA Bio & Diostech to acquire 30.6% stake in Skynewpharm - MarketLine Financial Deals
CHA Bio & Diostech to acquire 30.6% stake in Skynewpharm
Published Sep 26, 2012
2 pages — Published Sep 26, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

CHA Bio & Diostech Co., Ltd., a biotechnology company, has agreed to acquire 20 million new shares, representing a 30.6% stake, in Skynewpharm.

  
Source:
Document ID
MA125123_121016
Country
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "CHA Bio & Diostech to acquire 30.6% stake in Skynewpharm" Sep 26, 2012. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CHA-Bio-Diostech-to-acquire-30-6-stake-in-Skynewpharm-2052-87869>
  
APA:
MarketLine Financial Deals. (2012). CHA Bio & Diostech to acquire 30.6% stake in Skynewpharm Sep 26, 2012. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CHA-Bio-Diostech-to-acquire-30-6-stake-in-Skynewpharm-2052-87869>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.